Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
05/2003
05/22/2003CA2465861A1 Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
05/22/2003CA2464775A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
05/21/2003EP1311504A1 Tetrazolyl-phenyl acetamide glucokinase activators
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311497A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iv)
05/21/2003EP1311496A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iii)
05/21/2003EP1311495A2 Catalytic process for the preparation of thiazole derivatives
05/21/2003EP1311494A1 Continuous process for the preparation of pesticidal chlorothiazoles
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311160A1 2-phenyliminothiazolines, their preparation method and anti-rice blast agent containing the same
05/21/2003EP1283711A4 Peptide deformylase inhibitors
05/21/2003EP1115701B1 Arylsulfonanilide ureas
05/21/2003EP0971709B1 Novel compounds useful as neuro-protective agents
05/21/2003EP0970091B1 Process for the preparation of heteroaryl zinc halides
05/21/2003CN1419547A Compounds exhibiting thrombopoietin receptor agaonism
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1419536A Process for the selective N-formylation of n-hydroxylamines
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/21/2003CN1109024C Fluoric derivative of N-phenyl-3-oxazolylamine (thiazolylamine) and its preparing process and application
05/20/2003US6566530 Preparing 2-chloro-5-chloromethylthiazole by reacting 2-hydroxy-5-hydroxymethylthiazole with a chloride anion source in the presence of an acid.
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/20/2003US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer
05/20/2003US6566363 5-amino-3-substituted-pyrazolo(4,5-d)thiazole compounds that mediate and/or inhibit the activity of cyclin-dependent kinases, useful for treating cancer, angiogenesis and cellular proliferation
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/20/2003CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
05/20/2003CA2137694C Acaricide
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040142A1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
05/15/2003WO2003040129A1 Halogenated nitrobutadienes for controlling animal pests
05/15/2003WO2003040116A1 A process for the preparation of cephalosporins side chains
05/15/2003WO2003040115A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003WO2003040106A1 Preparation and use of substituted imidazoles
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2002030357A3 Compounds and methods for modulating ccr4 function
05/15/2003US20030092915 Using phase transfer catalyst and quaternary ammonium compound
05/15/2003US20030092747 Secretase inhibitor
05/15/2003US20030092743 Viricides; aids therapy
05/15/2003US20030092742 Catalytic hydrogenation
05/15/2003US20030092740 Anticoagulants
05/15/2003US20030092685 Administering a (bi- or tri)phenol compound containing a nitrogen ring
05/15/2003US20030092140 Novel polyketides and antibiotics
05/15/2003CA2669810A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465695A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/14/2003EP1310494A1 PPAR (delta) ACTIVATORS
05/14/2003EP1309577A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
05/14/2003EP1309576A1 Di(het)arylaminothiazole derivatives and their use in organic light-emitting diodes (oled's) and organic photovoltaic components
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309574A1 Method for purifying 2-chloro-5-chloromethyl thiazole
05/14/2003EP0994108B1 Process for producing 2-hydroxybenzamide derivatives
05/14/2003EP0970077B1 Improved method for producing thiazolidinediones, and new thiazolidinediones
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1108295C Thiol derivatives with metallopeptidase (ACE/NEP) inhibitory activity
05/13/2003US6562842 Osteoporosis, oral diseases
05/13/2003US6562817 Suppressants of the IgE production
05/13/2003US6562813 Aralkyl and aralkylidene heterocyclic lactams and imides
05/13/2003US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
05/13/2003CA2299959C Procedure for the preparation of dioxopenicillanic acid derivatives
05/08/2003WO2003037881A1 α-FORM OR ß-FORM CRYSTAL OF ACETANILIDE DERIVATIVE
05/08/2003WO2003037865A1 Novel anticancer compounds
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
05/08/2003WO2003037339A1 Interferon $g(g) production promoter
05/08/2003WO2003037338A2 Modulators of the cholesterol biosynthetic pathway
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003WO2003002595A3 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
05/08/2003US20030088105 Process for the preparation of substituted thiazolines and their intermediates
05/08/2003US20030087950 New alpha-amino acid sulphonyl compounds
05/08/2003US20030087945 Sulfonylaminocarboxylic acids
05/08/2003US20030087935 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
05/08/2003US20030087928 Novel anilide compounds and drugs containing the same
05/08/2003US20030087924 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003US20030087890 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide
05/08/2003US20030087888 Anticancer agents
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030087151 Low melting point
05/08/2003CA2468761A1 Novel anticancer compounds
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP1308436A1 Calcium receptor antagonists
05/07/2003EP1307462A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307193A1 Agonists of follicle stimulating hormone activity
05/07/2003EP1019358B1 3,3-diarylpropylamines , their use and preparation
05/07/2003EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments
05/07/2003EP0912510B1 Nickel catalyzed addition of -nh- containing compounds to vinyl and aryl halides
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0858464B1 Thrombin inhibitors
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/06/2003US6559341 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
05/06/2003US6559315 Phenyl- and pyridyl-substituted thiazoline acid derivatives useful in diagnosing and treating pathological conditions associated with an excess of trivalent metals in humans and animals.
05/06/2003US6559314 Reacting hexamethylenetetramine compound with cysteamine or its salts to produce thiazolidine
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/06/2003US6559140 Cyclic and bicyclic diamino histamine-3 receptor antagonists
05/06/2003US6559137 Characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 337